Upgrade to SI Premium - Free Trial

Biogen (BIIB): Mixed Results Keep Shares Steady For Now - Nomura

April 25, 2018 8:50 AM
Nomura/Instinet analyst, Christopher Marai, reiterated his Buy rating on shares of Biogen (NASDAQ: BiIB) after the company reported 1Q18 results ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View

Next Articles